India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation). However, it may take a couple of years before the vaccine is launched in the market for use. In January, this year, Hyderabad-based vaccine major announced that it entered a product transfer partnership with the pharma major GSK for its malaria vaccine, RTS, S/AS01E1.As part of this partnership, GSK would transfer RTS manufacturing technology to Bharat Biotech to produce the S antigen component of the malaria vaccine, and the license on all rights pertaining to it. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
Perspective
OPEN LETTER TO PRESIDENT BIDEN
Compensation Is Due from China; and If We Were Pearl Harbored, Then Reparations too- Ravi Batra New York based attorney Ravi Batra, on 14thApril 2020 wrote an open letter to then President Trump making out […]
Misc
Creating history, Air India flies Delhi-Israel direct flight via Saudi airspace
NEW YORK TIP): Saudi Arabia opened its airspace for the first time to a commercial flight to Israel with the inauguration on Thursday, March 22, of an Air India route between New Delhi and Tel […]
United States
Midwest Punjabi Association (MPA) in collaboration with the Consulate General of India set the precedent for paying tribute to “The Martyrs of the Jallianwala Bagh Massacre”
CHICAGO, IL (TIP): The celebration of Punjabi Virsa (Punjabi Heritage) organized by the Midwest Punjabi Association (MPA) in collaboration with the Consulate General of India set the precedent for paying the perfect tribute to the […]
Be the first to comment